{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:05Z","timestamp":1792783385646,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad de Navarra","id":[{"id":"https:\/\/ror.org\/02rxc7m23","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Background and aims: Albuminuria reflects renal and cardiovascular damage in type 2 diabetes (T2D), but its association is not fully understood. We evaluated the association of macroalbuminuria with cardiac structure and function. Methods: Cross-sectional study of 49 adults with T2D and stage 3 chronic kidney disease (CKD), stratified by macroalbuminuria, and 20 controls. Cardiac assessment included cardiac magnetic resonance (MRI), transthoracic echocardiography (TTE) and nine serum biomarkers, including soluble suppression of tumorigenicity 2 (sST2), a biomarker of myocardial stress and fibrosis. Results: Patients with T2D exhibited higher circulating levels of TIMP-1, MMP-10, neutrophil gelatinase-associated lipocalin (NGAL), NT-proBNP and hs-TnT than controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Among patients with T2D, macroalbuminuria was associated with an additional increase in TIMP-1 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Patients with T2D had higher T1 values in MRI scans, particularly those with macroalbuminuria (1051 ms [IQR: 1035\u20131074] vs. 1009 ms [IQR: 989\u20131020] in controls,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Although sST2 levels were higher in patients with T2D than in controls and tended to be higher in those with macroalbuminuria, these differences did not reach statistical significance. Nevertheless, higher T1 values were associated with higher sST2 levels, particularly in patients with macroalbuminuria (p for interaction\u2009&lt;\u20090.01). Among patients with macroalbuminuria, high sST2 levels were associated with higher T1 values (1071 ms [IQR: 1052\u20131087] vs. 1029 ms [IQR: 1013\u20131043],\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Conclusions: In T2D and stage 3 CKD, macroalbuminuria identifies a subgroup with more cardiac structural and functional abnormalities, particularly with elevated sST2. Prospective validation is needed.\n                  <\/jats:p>","DOI":"10.1007\/s13105-026-01236-5","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:27:10Z","timestamp":1789982830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macroalbuminuria as a marker of cardiac damage in patients with type 2 diabetes: insights from multimodality cardiac imaging and biomarkers"],"prefix":"10.1007","volume":"82","author":[{"given":"Xabier Irazusta","family":"Olloquiegui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa Echeverria","family":"Andueza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pascual","family":"Izco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo Luis Alonso","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto Fern\u00e1ndez","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Ravassa","family":"Alb\u00e9niz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio M.","family":"Solis-Barquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Aramend\u00eda-Vidaurreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Mora-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josune","family":"Orbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Fern\u00e1ndez-Seara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1082-0806","authenticated-orcid":false,"given":"Nuria","family":"Garc\u00eda-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"publisher","first-page":"100739","DOI":"10.1016\/j.eclinm.2021.100739","volume":"32","author":"A Claire","year":"2021","unstructured":"Claire A, Lawson S, Seidu F, Zaccardi et al (2021) Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years. EClinicalMedicine 32:100739","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1236_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.recesp.2023.05.004","volume":"77","author":"M Cobo Marcos","year":"2024","unstructured":"Cobo Marcos M, de la Espriella R, Gay\u00e1n Ord\u00e1s J et al (2024) Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry. Rev Esp Cardiol (Engl Ed) 77(1):50\u201359","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"1236_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2337\/db20211-13","volume":"2021","author":"MS Usman","year":"2021","unstructured":"Usman MS, Khan MS, Butler J (2021) The Interplay Between Diabetes, Cardiovascular Disease, and Kidney Disease. ADA Clin Compendia [Internet] 2021(1):13\u201318","journal-title":"ADA Clin Compendia [Internet]"},{"issue":"1","key":"1236_CR4","first-page":"1","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP (2023) The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol [Internet] 22(1):1\u201312","journal-title":"Cardiovasc Diabetol [Internet]"},{"issue":"3","key":"1236_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jamacardio.2020.5921","volume":"6","author":"MC Honigberg","year":"2021","unstructured":"Honigberg MC, Patel RB, Pandey A et al (2021) Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes. JAMA Cardiol 6(3):354\u2013357","journal-title":"JAMA Cardiol"},{"key":"1236_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2022.02.009","volume":"355","author":"X Dieu","year":"2022","unstructured":"Dieu X, Chabrun F, Prunier F, Angoulvant D, Mewton N, Roubille F et al (2022) Post-infarct cardiac remodeling predictions with machine learning. Int J Cardiol 355:1\u20134","journal-title":"Int J Cardiol"},{"issue":"990","key":"1236_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/hrt.2005.067231","volume":"84","author":"TH Marwick","year":"2008","unstructured":"Marwick TH (2008) Diabetic heart disease. Postgrad Med J 84(990):188\u2013192","journal-title":"Postgrad Med J"},{"issue":"20","key":"1236_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS et al (2023) A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation 148(20):1636\u20131664","journal-title":"Circulation"},{"issue":"3","key":"1236_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/jcm13030777","volume":"13","author":"G Romero-Gonz\u00e1lez","year":"2024","unstructured":"Romero-Gonz\u00e1lez G, Rodr\u00edguez-Chitiva N, Ca\u00f1ameras C et al (2024) Albuminuria, Forgotten No More: Underlining the Emerging Role in CardioRenal Crosstalk. J Clin Med 13(3):777","journal-title":"J Clin Med"},{"issue":"7","key":"1236_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4065\/83.7.806","volume":"83","author":"J Danziger","year":"2008","unstructured":"Danziger J (2008) Importance of low-grade albuminuria. Mayo Clin Proc 83(7):806\u2013812","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1236_CR11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.amjcard.2019.06.011","volume":"124","author":"ACT Ng","year":"2019","unstructured":"Ng ACT, Bertini M, Ewe SH, van der Velde ET, Leung DY, Delgado V, Bax JJ (2019) Defining Subclinical Myocardial Dysfunction and Implications for Patients With Diabetes Mellitus and Preserved Ejection Fraction. Am J Cardiol 124(6):892\u2013898","journal-title":"Am J Cardiol"},{"issue":"12","key":"1236_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.echo.2008.09.013","volume":"21","author":"NC Edwards","year":"2008","unstructured":"Edwards NC, Hirth A, Ferro CJ, Townend JN, Steeds RP (2008) Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy? J Am Soc Echocardiogr 21(12):1293\u20131298","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"1236_CR13","doi-asserted-by":"publisher","first-page":"e005539","DOI":"10.1161\/JAHA.117.005539","volume":"6","author":"PP Swoboda","year":"2017","unstructured":"Swoboda PP, McDiarmid AK, Erhayiem B, Ripley DP, Dobson LE, Garg P et al (2017) Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure. J Am Heart Assoc 6(7):e005539","journal-title":"J Am Heart Assoc"},{"key":"1236_CR14","doi-asserted-by":"publisher","unstructured":"Garcia-Fernandez N, Jacobs-Cach\u00e1 C, Mora-Guti\u00e9rrez JM, Vergara A, Orbe J, Soler MJ (2020) Matrix Metalloproteinases in Diabetic Kidney Disease. J Clin Med 9(2):472. https:\/\/doi.org\/10.3390\/jcm9020472","DOI":"10.3390\/jcm9020472"},{"key":"1236_CR15","doi-asserted-by":"publisher","first-page":"101194","DOI":"10.1016\/j.mam.2023.101194","volume":"93","author":"S Ravassa","year":"2023","unstructured":"Ravassa S, L\u00f3pez B, Treibel TA, San Jos\u00e9 G, Losada-Fuentenebro B, Tapia L et al (2023) Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies. Mol Aspects Med 93:101194","journal-title":"Mol Aspects Med"},{"issue":"6","key":"1236_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ejhf.2201","volume":"23","author":"AG Raafs","year":"2021","unstructured":"Raafs AG, Verdonschot JAJ, Henkens MTHM, Adriaans BP, Wang P, Derks K et al (2021) The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy \u2013 A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy. Eur J Heart Fail 23(6):933\u2013944","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"1236_CR17","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","volume":"112","author":"H Izawa","year":"2005","unstructured":"Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T et al (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112(19):2940\u20132945","journal-title":"Circulation"},{"issue":"12","key":"1236_CR18","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00125-013-3052-4","volume":"56","author":"M Toni","year":"2013","unstructured":"Toni M, Hermida J, Go\u00f1i MJ, Fern\u00e1ndez P, Parks WC, Toledo E et al (2013) Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients. Diabetologia 56(12):2743\u20132752","journal-title":"Diabetologia"},{"key":"1236_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ijms241310470","volume":"24","author":"K Romejko","year":"2023","unstructured":"Romejko K, Markowska M, Niemczyk S (2023) The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int J Mol Sci 24:13","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1236_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","volume":"14","author":"CP McCarthy","year":"2018","unstructured":"McCarthy CP, Januzzi JL (2018) Soluble ST2 in Heart Failure. Heart Fail Clin 14(1):41\u201348","journal-title":"Heart Fail Clin"},{"issue":"1","key":"1236_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12265-017-9775-8","volume":"11","author":"CCS Tseng","year":"2018","unstructured":"Tseng CCS, Huibers MMH, van Kuik J, de Weger RA, Vink A, de Jonge N (2018) The Interleukin-33\/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium. J Cardiovasc Transl Res 11(1):15\u201321","journal-title":"J Cardiovasc Transl Res"},{"key":"1236_CR22","doi-asserted-by":"publisher","first-page":"110814","DOI":"10.1016\/j.clinbiochem.2024.110814","volume":"131\u2013132","author":"A Cordero","year":"2024","unstructured":"Cordero A, Velasco I, Flores E, L\u00f3pez-Ayala JM, S\u00e1nchez-Munuera S, Mu\u00f1oz-Villalba MP et al (2024) Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes. Clin Biochem 131\u2013132:110814","journal-title":"Clin Biochem"},{"key":"1236_CR23","doi-asserted-by":"publisher","unstructured":"Zannad F, Ferreira JP, Pocock SJ, Anker SD, Butler J, Filippatos G et al (2020) SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet 396(10254):819\u2013829. https:\/\/doi.org\/10.1016\/S0140-6736(20)31824-9","DOI":"10.1016\/S0140-6736(20)31824-9"},{"issue":"16","key":"1236_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M et al (2021) Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 385(16):1451\u20131461","journal-title":"N Engl J Med"},{"issue":"15","key":"1236_CR25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P et al (2020) Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 383(15):1413\u20131424","journal-title":"N Engl J Med"},{"issue":"12","key":"1236_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF et al (2022) Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 387(12):1089\u20131098","journal-title":"N Engl J Med"},{"issue":"21","key":"1236_CR27","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA et al (2019) Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 381(21):1995\u20132008","journal-title":"N Engl J Med"},{"issue":"12","key":"1236_CR28","first-page":"1181","volume":"390","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS et al (2024) Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 390(12):1181\u20131192","journal-title":"N Engl J Med"},{"issue":"9","key":"1236_CR29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"key":"1236_CR30","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/ehjci\/jex231","volume":"19","author":"PG J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen PG et al (2018) Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes. Eur Heart J Cardiovasc Imaging 19:1034\u20131041 PMID: 29029007. https:\/\/doi.org\/10.1093\/ehjci\/jex231","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1236_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-015-0201-8","volume":"14","author":"Y Mochizuki","year":"2015","unstructured":"Mochizuki Y et al (2015) Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus. Cardiovasc Diabetol 14:37 PMID: 25889250. https:\/\/doi.org\/10.1186\/s12933-015-0201-8","journal-title":"Cardiovasc Diabetol"},{"key":"1236_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4103\/jcecho.jcecho_36_21","volume":"31","author":"YA Abdellatif","year":"2021","unstructured":"Abdellatif YA et al (2021) A subtle decline in cardiac mechanics is correlated with albuminuria in asymptomatic normotensive patients with type 2 diabetes mellitus: a two-dimensional strain echocardiography study. J Cardiovasc Echogr 31:220\u2013226 PMID: 35284219","journal-title":"J Cardiovasc Echogr"},{"issue":"11","key":"1236_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.echo.2025.07.007","volume":"38","author":"JD Thomas","year":"2025","unstructured":"Thomas JD, Edvardsen T, Abraham T, Appadurai V, Badano L, Banchs J et al (2025) Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography. J Am Soc Echocardiogr 38(11):985\u20131020","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"1236_CR34","doi-asserted-by":"publisher","first-page":"106914","DOI":"10.4239\/wjd.v16.i9.106914","volume":"16","author":"F Barutta","year":"2025","unstructured":"Barutta F, Andreis A, Bellettini M, Beccuti G, Ferro A, Bollati M et al (2025) Albuminuria is independently associated with preclinical left ventricular systolic dysfunction: The TESEO study. World J Diabetes 16(9):106914","journal-title":"World J Diabetes"},{"issue":"11","key":"1236_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/jcdd10110468","volume":"10","author":"M Riccardi","year":"2023","unstructured":"Riccardi M, Myhre PL, Zelniker TA, Metra M, Januzzi JL, Inciardi RM (2023) Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide. J Cardiovasc Dev Dis 10(11):468","journal-title":"J Cardiovasc Dev Dis"},{"issue":"8","key":"1236_CR36","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/biom11081167","volume":"11","author":"A Merino-Merino","year":"2021","unstructured":"Merino-Merino A, Gonzalez-Bernal J, Fernandez-Zoppino D, Saez-Maleta R, Perez-Rivera JA (2021) The Role of Galectin-3 and ST2 in Cardiology: A Short Review. Biomolecules 11(8):1167","journal-title":"Biomolecules"},{"key":"1236_CR37","first-page":"100887","volume":"37","author":"C Ip","year":"2021","unstructured":"Ip C, Luk KS, Yuen VLC, Chiang L, Chan CK, Ho K et al (2021) Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis. Int J Cardiol Heart Vasc 37:100887","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"6","key":"1236_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/14017431.2015.1076936","volume":"49","author":"S Quick","year":"2015","unstructured":"Quick S, Waessnig NK, Kandler N, Poitz DM, Schoen S, Ibrahim K et al (2015) Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance. Scand Cardiovasc J 49(6):361\u2013366","journal-title":"Scand Cardiovasc J"},{"issue":"7 Suppl","key":"1236_CR39","doi-asserted-by":"publisher","first-page":"59B","DOI":"10.1016\/j.amjcard.2015.01.042","volume":"115","author":"C deFilippi","year":"2015","unstructured":"deFilippi C, Daniels LB, Bayes-Genis A (2015) Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography. Am J Cardiol 115(7 Suppl):59B\u201363B","journal-title":"Am J Cardiol"},{"issue":"3","key":"1236_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","volume":"55","author":"RA Weir","year":"2010","unstructured":"Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM et al (2010) Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol 55(3):243\u2013250","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1236_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jchf.2014.05.016","volume":"2","author":"DH Katz","year":"2014","unstructured":"Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ (2014) Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2(6):586\u2013596","journal-title":"JACC Heart Fail"},{"issue":"23","key":"1236_CR42","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P et al (2020) Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 383(23):2219\u20132229","journal-title":"N Engl J Med"},{"issue":"15","key":"1236_CR43","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stef\u00e1nsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF et al (2020) Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 383(15):1436\u20131446","journal-title":"N Engl J Med"},{"issue":"1","key":"1236_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jchf.2022.09.008","volume":"11","author":"S Ravassa","year":"2023","unstructured":"Ravassa S, Lup\u00f3n J, L\u00f3pez B, Codina P, Domingo M, Revuelta-L\u00f3pez E et al (2023) Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides. JACC Heart Fail 11(1):58\u201372","journal-title":"JACC Heart Fail"},{"key":"1236_CR45","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3390\/nu14173484","volume":"14","author":"D Abasheva","year":"2022","unstructured":"Abasheva D, Dolcet-Negre MM, Fern\u00e1ndez-Seara MA, Mora-Guti\u00e9rrez JM, Orbe J, Escalada FJ, Garcia-Fernandez N (2022) Association between Circulating Levels of 25-Hydroxyvitamin D3 and Matrix Metalloproteinase-10 (MMP-10) in Patients with Type 2 Diabetes. Nutrients 14:3484","journal-title":"Nutrients"},{"issue":"1","key":"1236_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC et al (2019) Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32(1):1\u201364","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"1236_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52(1):141\u2013146","journal-title":"Magn Reson Med"},{"issue":"3","key":"1236_CR48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/jmri.21028","volume":"26","author":"H Abdel-Aty","year":"2007","unstructured":"Abdel-Aty H, Simonetti O, Friedrich MG (2007) T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 26(3):452\u2013459","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1236_CR49","doi-asserted-by":"publisher","first-page":"e4077","DOI":"10.1002\/nbm.4077","volume":"32","author":"V Aramend\u00eda-Vidaurreta","year":"2019","unstructured":"Aramend\u00eda-Vidaurreta V, Garc\u00eda-Os\u00e9s A, Vidorreta M, Bastarrika G, Fern\u00e1ndez-Seara MA (2019) Optimal repetition time for free breathing myocardial arterial spin labeling. NMR Biomed 32(5):e4077","journal-title":"NMR Biomed"},{"key":"1236_CR50","doi-asserted-by":"publisher","unstructured":"Aramend\u00eda-Vidaurreta V, Echeverr\u00eda-Chasco R, Vidorreta M, Bastarrika G, Fern\u00e1ndez-Seara MA (2020) Quantification of myocardial perfusion with vasodilation using arterial spin labeling at 1.5T. J Magn Reson Imaging 53(3):777\u2013788. https:\/\/doi.org\/10.1002\/jmri.27396","DOI":"10.1002\/jmri.27396"},{"issue":"3","key":"1236_CR51","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/mrm.29038","volume":"87","author":"V Aramend\u00eda-Vidaurreta","year":"2022","unstructured":"Aramend\u00eda-Vidaurreta V, Gordaliza PM, Vidorreta M, Echeverr\u00eda-Chasco R, Bastarrika G, Mu\u00f1oz-Barrutia A, Fern\u00e1ndez-Seara MA (2022) Reduction of motion effects in myocardial arterial spin labeling. Magn Reson Med 87(3):1261\u20131275","journal-title":"Magn Reson Med"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01236-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:04:31Z","timestamp":1789988671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01236-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01236-5","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"96"}}